NTHI vs XLI
NeOnc Technologies Holdings, Inc. Common Stock (NTHI) versus XLI (XLI) — a side-by-side from cached financials, not a winner call.
NeOnc Technologies Holdings, Inc. Common Stock (NTHI) is a biotechnology company listed on NASDAQ.
XLI (XLI) common stock.
Latest reported NTHI revenue for 2025-12-31 was $40.0K. Net income was -$62.1M. Revenue was down 51.8% from 2024-12-31 to 2025-12-31. NTHI currently screens at market cap $117.3M.
XLI does not have a complete income-statement cache yet.
NTHI currently screens at market cap $117.3M. XLI currently screens at market cap $0.
Not investment advice. Open the NTHI and XLI stock pages for the full models.
Not investment advice.